Telogen effluvium is a scalp disorder characterized by the thinning or shedding of hair resulting from the early entry of hair follicles into the telogen phase (resting phase). Unlike conditions like alopecia areata, which result in localized bald patches, telogen effluvium manifests as diffuse hair thinning. This article provides a comprehensive overview of telogen effluvium and evaluates the potential efficacy of topical treatments, namely minoxidil and finasteride, in managing the condition.
Unraveling Telogen Effluvium
Pathophysiology
Hair growth occurs in cycles: the anagen (growth), catagen (transitional), and telogen (resting) phases. At any given time, various hairs across the scalp will be in different phases. Telogen effluvium arises when a significant number of hairs prematurely enter the telogen phase, leading to an increased amount of hair shedding.
Several triggers can initiate this shift:
- Physical or emotional stress
- Hormonal changes (e.g., postpartum)
- Illness or surgery
- Significant weight loss
- Iron deficiency
- Some medications
The hair loss is often noticed a few months after the inciting event.
Clinical Presentation
Patients typically present with generalized hair thinning rather than distinct bald patches. An increased number of hairs may come out while brushing or washing. Fortunately, in many cases, the hair loss is temporary, and once the triggering factor is addressed, the hair often regrows.
Treatment and Management
Minoxidil
Minoxidil is a vasodilator initially designed to treat hypertension. It was serendipitously found to induce hair growth when applied topically. Its exact mechanism in stimulating hair follicles remains uncertain.
In the context of telogen effluvium, minoxidil is believed to shift the hair follicles from the telogen phase back to the anagen phase. Numerous studies suggest that minoxidil can accelerate the recovery from telogen effluvium and boost the thickness and coverage of hair during the regrowth phase.
It’s worth noting that minoxidil’s effects are not immediate and consistent use over several months is often necessary before noticeable results emerge. Furthermore, discontinuation can lead to a cessation of the benefits, making continuous application crucial for sustained results.
Finasteride
Finasteride primarily serves as a treatment for androgenetic alopecia (male pattern baldness) by inhibiting the enzyme responsible for converting testosterone to dihydrotestosterone (DHT) – a hormone implicated in hair follicle miniaturization.
Its direct impact on telogen effluvium is less clear. Considering that the pathophysiology of telogen effluvium is different from androgenetic alopecia, the rationale for finasteride use in telogen effluvium is not as strong. However, in cases where both conditions overlap, finasteride might offer benefits.
Best value products
